Skip to main content
eScholarship
Open Access Publications from the University of California

UC Santa Cruz

UC Santa Cruz Previously Published Works bannerUC Santa Cruz

Whole-genome characterization of lung adenocarcinomas lacking the RTK/RAS/RAF pathway.

  • Author(s): Carrot-Zhang, Jian;
  • Yao, Xiaotong;
  • Devarakonda, Siddhartha;
  • Deshpande, Aditya;
  • Damrauer, Jeffrey S;
  • Silva, Tiago Chedraoui;
  • Wong, Christopher K;
  • Choi, Hyo Young;
  • Felau, Ina;
  • Robertson, A Gordon;
  • Castro, Mauro AA;
  • Bao, Lisui;
  • Rheinbay, Esther;
  • Liu, Eric Minwei;
  • Trieu, Tuan;
  • Haan, David;
  • Yau, Christina;
  • Hinoue, Toshinori;
  • Liu, Yuexin;
  • Shapira, Ofer;
  • Kumar, Kiran;
  • Mungall, Karen L;
  • Zhang, Hailei;
  • Lee, Jake June-Koo;
  • Berger, Ashton;
  • Gao, Galen F;
  • Zhitomirsky, Binyamin;
  • Liang, Wen-Wei;
  • Zhou, Meng;
  • Moorthi, Sitapriya;
  • Berger, Alice H;
  • Collisson, Eric A;
  • Zody, Michael C;
  • Ding, Li;
  • Cherniack, Andrew D;
  • Getz, Gad;
  • Elemento, Olivier;
  • Benz, Christopher C;
  • Stuart, Josh;
  • Zenklusen, JC;
  • Beroukhim, Rameen;
  • Chang, Jason C;
  • Campbell, Joshua D;
  • Hayes, D Neil;
  • Yang, Lixing;
  • Laird, Peter W;
  • Weinstein, John N;
  • Kwiatkowski, David J;
  • Tsao, Ming S;
  • Travis, William D;
  • Khurana, Ekta;
  • Berman, Benjamin P;
  • Hoadley, Katherine A;
  • Robine, Nicolas;
  • TCGA Research Network;
  • Meyerson, Matthew;
  • Govindan, Ramaswamy;
  • Imielinski, Marcin
  • et al.
Abstract

RTK/RAS/RAF pathway alterations (RPAs) are a hallmark of lung adenocarcinoma (LUAD). In this study, we use whole-genome sequencing (WGS) of 85 cases found to be RPA(-) by previous studies from The Cancer Genome Atlas (TCGA) to characterize the minority of LUADs lacking apparent alterations in this pathway. We show that WGS analysis uncovers RPA(+) in 28 (33%) of the 85 samples. Among the remaining 57 cases, we observe focal deletions targeting the promoter or transcription start site of STK11 (n = 7) or KEAP1 (n = 3), and promoter mutations associated with the increased expression of ILF2 (n = 6). We also identify complex structural variations associated with high-level copy number amplifications. Moreover, an enrichment of focal deletions is found in TP53 mutant cases. Our results indicate that RPA(-) cases demonstrate tumor suppressor deletions and genome instability, but lack unique or recurrent genetic lesions compensating for the lack of RPAs. Larger WGS studies of RPA(-) cases are required to understand this important LUAD subset.

Many UC-authored scholarly publications are freely available on this site because of the UC's open access policies. Let us know how this access is important for you.

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View